20820 Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices 

ADDRESSES: Comments maybe submitted 

electronically on www.regulations.gov 

or by mail to Arnold Chow, Export 

Import Bank of the United States, 811 

Vermont Ave. NW., Washington, DC 

20571. 

SUPPLEMENTARY INFORMATION: Titles and 

Form Number: EIB 94–08 Notification 

and Assignment by Insured to Financial 

Institution of Medium Term Export 

Credit Insurance Policy. 

OMB Number: 3048–xxx. 

Type of Review: Regular. 

Need and Use: The form transfers the 

duties and obligations of the insured 

exporter to the financial institution. It 

also provides certifications to the 

financial institution and Ex-Im Bank 

that the financed export transaction 

results in a valid, enforceable, and 

performing debt obligation. Exporter 

policy holders need this form to obtain 

financing for their medium term export 

sales. 

Affected Public: This form affects 

entities involved in the export of U.S 

goods and services. 

Annual Number of Respondents: 50. 

Estimated Time per Respondent: 10 

minutes. 

Government Annual Burden Hours: 5 

hours. 

Frequency of Reporting or Use: As 

needed. 

Sharon A. Whitt, 

Agency Clearance Officer. 

[FR Doc. 2012–8309 Filed 4–5–12; 8:45 am] 

BILLING CODE 6690–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

notices are set forth in paragraph 7 of 

the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than April 23, 

2012. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. The Duncan, Hrvol, and Molzen 

Families consisting of E. Ray Duncan, 

individually and as beneficiary of the 

Hardware State Bank 401K Plan and as 

beneficiary of the Sullivan Bancshares, 

Inc. Employee Savings and Retirement 

Plan, together as a group acting in 

concert with Sally Foley Duncan and 

Sally Foley Duncan, as Trustee of the 

John K. Foley Revocable Living Trust 

and as beneficiary of the Hardware State 

Bank 401K Plan, the John K. Foley 

Revocable Living Trust, and Gloria 

Foley, all of Lovington, Illinois, and 

Paul Michael Hrvol, Jr. and Paul 

Michael Hrvol, Jr., as beneficiary of the 

Sullivan Bancshares, Inc. Employee 

Savings and Retirement Plan, Michelle 

Beth Hrvol and Michelle Beth Hrvol, as 

beneficiary of the Sullivan Bancshares, 

Inc. Employee Savings and Retirement 

Plan, all of Sullivan, Illinois, and Roger 

Reid Molzen and Roger Reid Molzen, as 

beneficiary of the Sullivan Bancshares, 

Inc. Employee Savings and Retirement 

Plan and Christina DeAnne Molzen, all 

of Sullivan, Illinois, collectively as a 

group acting in concert, to retain shares 

of Moultrie Bancorp, Inc. and thereby 

indirectly control Hardware State Bank, 

both of Lovington, Illinois. 

Board of Governors of the Federal Reserve 

System, April 3, 2012. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2012–8321 Filed 4–5–12; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality Agency 

Information Collection Activities: 

Proposed Collection; Comment 

Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project: 

‘‘Synthesis of AHRQ–Funded HAI 

Projects.’’ In accordance with the 

Paperwork Reduction Act, 44 U.S.C. 

3501–3521, AHRQ invites the public to 

comment on this proposed information 

collection. 

DATES: Comments on this notice must be 

received by June 5, 2012. 

ADDRESSES: Written comments should 

be submitted to: Doris Leflcowitz, 

Reports Clearance Officer, AHRQ, by 

email at doris.leflcowitz@AHRQ.hhs.

gov. 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Leflcowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.leflcowitz@AHR.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Synthesis of AHRQ–Funded HAI 

Projects 

The Agency for Healthcare Research 

and Quality (AHRQ) requests that the 

Office of Management and Budget 

(OMB) approve, under the Paperwork 

Reduction Act of 1995, AHRQ’s 

collection of information for the 

Synthesis of AHRQ–Funded HAI 

Projects. 

For approximately a decade, AHRQ 

has conducted research on preventing 

healthcareassociated infections (HAIs), 

both internally and through contracts 

and grants. AHRQ’s grant- and contractsupported projects have been directed at 

the major types of HAIs: Central-lineassociated bloodstream infections 

(CLABSI), catheter-associated urinary 

tract infections (CAUTI), surgical site 

infections (S SI), ventilator-associated 

pneumonia (VAP), methicillin-resistant 

Staphylococcus aureus (MRSA), and 

Clostridium difficile (C. cliff.). Projects 

have addressed the problem of HAIs in 

diverse healthcare settings, including 

hospitals, ambulatory settings 

(ambulatory surgery centers, end-stage 

renal disease facilities, and outpatient 

clinics and offices), and long-term care 

facilities. AHRQ’s portfolio of HAI 

projects has emphasized a combination 

of research and implementation 

initiatives. In the latter category, a major 

focus of AHRQ’s efforts has been to 

deploy tools that can improve provider 

performance and reduce HAIs. Based on 

the earlier success of the Michigan 

Keystone project, AHRQ has funded 

projects to implement the 

Comprehensive Unit-based Safety 

Program (CUSP) to address CLABSI and 

CAUTI nationwide. Data are now 

emerging that demonstrate the success 

of CUSP in reducing CLABSI in 

hospitals across the nation. 

Between 2007 and 2010, AHRQ 

funded 40 contracts and 18 grants 

focusing on expanding the HAI 

knowledge base and implementing HAI 

prevention strategies. Today it is 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices 20821 

necessary to look across these projects 

in order to (1) identify, document, and 

synthesize their findings and results to 

ensure that AHRQ, healthcare 

professionals, and the public can make 

best use of these findings and (2) 

identify remaining gaps in the HAI 

science base to enable AHRQ to fund 

future studies that will address these 

needs. The synthesis will draw on 

several data sources, including 

interviews with project leaders. In 

addition to learning about studies that 

have not published peer-reviewed 

manuscripts, the interviews will enable 

the project team to delve into project 

details that are not typically available in 

publications, such as the project leader’s 

motivation for responding to the request 

for proposal, challenges faced in 

implementing the project, changes in 

the project’s delivery schedule or work 

plan, experts’ views on how HAI 

prevention evidence generated by a 

specific project fits into the HAI 

research agenda more broadly, and 

remaining gaps in the HAI knowledge 

base. 

AHRQ has contracted with IMPAQ 

International, LLC, to develop this 

synthesis, identify gaps, and promote 

the widespread application of 

successful HAI prevention approaches. 

This research has the following goals: 

(1) Identify and document findings and 

synthesize results of AHRQ-funded HAI 

projects; (2) Disseminate key findings 

from the HAI projects; and (3) Identify 

remaining gaps in the HAI knowledge 

base. 

This study is being conducted by 

AHRQ through its contractor, IMPAQ 

International, LLC and its subcontractor, 

the RAND Corporation, pursuant to 

AHRQ’s statutory authority to conduct 

and support research and disseminate 

information on healthcare and on 

systems for the delivery of such care, 

including activities with respect to the 

quality, effectiveness, efficiency, 

appropriateness and value of healthcare 

services and with respect to quality 

measurement and improvement. 42 

U.S.C. 299a(a)(1) and (2). 

Method of Collection 

To achieve the goals of this project the 

following data collection will be 

implemented: 

(1) Interviews with contractors— 

Interviews will be conducted with the 

project leaders (project directors or 

project managers) from 40 HAT 

contractors. The purpose of these 

interviews is to identify (a) key findings, 

(b) gaps in knowledge base, (c) lessons 

learned, (d) effective approaches for 

preventing and reducing HAIs, and e) 

opportunities for additional projects 

focused on generating and 

implementing knowledge on preventing 

HAIs. 

(2) Interviews with grantees— 

Interviews will be conducted with the 

project leaders (principal investigators) 

from 18 HAI grantees. Similar to the 

interviews with contractors, the purpose 

of these interviews is to identify (a) key 

findings, (b) gaps in knowledge base, (c) 

lessons learned, (d) effective approaches 

for preventing and reducing HAIs, and 

(e) opportunities for additional projects 

focused on generating and 

implementing knowledge on preventing 

HAIs. While the goals of the interviews 

with contractors and grantees are 

similar, the two audiences require 

separate interview protocols because 

their funding mechanisms and project 

structures differ. For example, contracts 

have more structured deliverable 

schedules than do grants and grants are 

more likely than contracts to be on 

investigator-initiated topics. 

AHRQ will interview key project 

leaders to learn about the processes and 

methods used, results achieved, and 

lessons learned under the AHRQ-funded 

HAI contracts and grants. This 

information will enable AHRQ to 

identify effective approaches for 

preventing and reducing HAIs and for 

promoting the widespread application 

of these approaches. Finally, collecting 

data from these audiences will allow 

AHRQ to detect gaps in the HAI science 

base and identify opportunities for 

additional projects focused on 

generating and implementing 

knowledge on preventing HAIs. 

Estimated Annual Respondent Burden 

Exhibit 1 shows the estimated 

annualized burden hours for the 

respondent’s time to participate in this 

evaluation. Interviews will be 

conducted with 40 contractors and 18 

grantees and each will last about 90 

minutes. The total burden hours are 

estimated to be 87. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Data collection activity Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Interviews with contractors .............................................................. 40 1 1.5 60 

Interviews with grantees .................................................................. 18 1 1.5 27 

Total .......................................................................................... 58 n/a n/a 87 

The respondents are the project 

leaders, that is, project directors for the 

contracts and principal investigators for 

the grants. Based on the type of grant 

and the project leaders’ qualifications, 

the project leaders were categorized into 

three labor categories: Social Scientists 

and Related Workers; Epidemiologists; 

and Medical Scientists. For example, 

one project director conducting a 

randomized controlled trial is a 

physician and was categorized into the 

Medical Scientist labor category. Other 

project leaders have advanced degrees 

in the social sciences (e.g., gerontology) 

or epidemiology and were included in 

the Social Scientist or Epidemiologist 

labor categories, as appropriate. 

Exhibit 2 shows the estimated 

annualized cost burden associated with 

the respondent’s time to participate in 

the evaluation. The total cost burden is 

estimated to be $3,450. 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Data collection activity Number of 

respondents 

Total burden 

hours 

Average hourly 

wage rate* Total cost burden 

Interviews with contractors .............................................................. 40 60 $39.66 $2,380 

Interviews with grantees .................................................................. 18 27 39.66 1,070 

mstockstill on DSK4VPTVN1PROD with NOTICES

20822 Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued 

Data collection activity Number of 

respondents 

Total burden 

hours 

Average hourly 

wage rate* Total cost burden 

Total .......................................................................................... 58 87 n/a 3,450 

*

Base upon the weighted average of the mean wages for 19–3099 Social Scientists and Related Workers, All Other ($37.45 per hour; n = 17), 

19–1041 Epidemiologists ($32.83; n = 5) and 19–1042 Medical Scientists (($41.69; n = 36), National Compensation Survey: Occupational Wages 

in the United States May 2010, U.S. Department of Labor, Bureau of Labor Statistics. 

Estimated Annual Costs to the Federal 

Government 

Exhibit 3 shows the estimated total 

and annualized cost to the government 

for conducting the evaluation. The total 

cost is estimated to be $87,502. 

EXHIBIT 3—ESTIMATED TOTAL AND

ANNUALIZED COST

Cost component Total cost Annualized 

cost 

Project Development .................. $6,135 $2,045 

Data Collection Activities ................ 17,400 5,800 

Data Processing 

and Analysis ...... 29,000 9,667 

Publication of Results ................... 0 0 

Project Management .................. 5,800 1,933 

Overhead .............. 29,167 9,722 

Total ............... 87,502 29,167 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: March 29, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–8098 Filed 4–5–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Detecting Emerging VectorBorne Zoonotic Pathogens in Indonesia, 

Funding Opportunity Announcement 

(FOA) CK12–002, initial review. 

Correction: The notice was published 

in the Federal Register on March 2, 

2012, Volume 77, Number 42, Page 

12844. The time and date should read 

as follows: 

Time and Date: 1 p.m.–3 p.m., April 

16, 2012 (Closed). 

Contact Person for More Information: 

Gregory Anderson, M.P.H., M.S., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE., Mailstop E60, 

Atlanta, Georgia 30333, Telephone: 

(404) 718–8833. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 30, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–8286 Filed 4–5–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Identifying Modifiable 

Protective Factors for Intimate Partner 

Violence or Sexual Violence 

Perpetration, Funding Opportunity 

Announcement (FOA) CE12–003, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12 p.m.–3 p.m., April 26, 

2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Identifying Modifiable 

Protective Factors for Intimate Partner 

Violence or Sexual Violence Perpetration, 

FOA CE12–003’’. 

Contact Person for More Information: Jane 

Suen, Dr.P.H., M.S., Scientific Review 

Officer, CDC, 4770 Buford Highway, NE., 

Mailstop F63, Atlanta, Georgia 30341–3724, 

Telephone (770) 488–4281. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 30, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–8285 Filed 4–5–12; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES